CLX: the cashflow

MyFinsight

For the quarter ending 2025-12-31, CLX had $60M increase in cash & cash equivalents over the period. $269M in free cash flow.

Unit: Million (M) dollars (except for numbers of shares and EPS)

Cash Flow	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Net earnings	161	82	336	191
Depreciation and amortization	55	56	57	55
Stock-based compensation	24	10	17	24
Deferred income taxes	8	84	-2	3
Loss on divestiture	0	0	0	0
Pension settlement charge	-	-	0	0
Goodwill, trademark and other asset impairments	-	-	0	-
Other	4	12	17	14
Receivables, net	-38	-118	216	-7
Inventories, net	28	55	-117	42
Prepaid expenses and other current assets	-11	41	-19	-11
Accounts payable and accrued liabilities	34	-40	-37	51
Operating lease right-of-use assets and liabilities, net	-2	-2	1	1
Income taxes payable / prepaid	14	-107	19	-1
Net cash provided by operations	311	93	294	286
Capital expenditures	42	36	75	53
Proceeds from divestiture, net of cash divested	0	0	0	0
Other	1	-2	1	0
Net cash (used for) provided by investing activities	-43	-34	-76	-53
Notes and loans payable, net	89	214	-50	-134
Treasury stock purchased	127	129	75	0
Cash dividends paid to clorox stockholders	151	151	150	150
Cash dividends paid to noncontrolling interests	-	-	0	16
Issuance of common stock for employee stock plans and other	-21	7	-4	1
Net cash used for financing activities	-210	-59	-279	-299
Effect of exchange rate changes on cash, cash equivalents and restricted cash	2	-1	2	1
Net increase (decrease) in cash, cash equivalents and restricted cash	60	-1	-59	-65
Cash and cash equivalents at beginning of period	169	170	229	294
Cash and cash equivalents at end of period	229	169	170	229

Unit: Million (M) dollars